Connection
David Hall to Lung Neoplasms
This is a "connection" page, showing publications David Hall has written about Lung Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.188 |
|
|
|
-
Ortendahl JD, Cuyun Carter G, Thakkar SG, Bognar K, Hall DW, Abdou Y, Gandara D. Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non-Small Cell Lung Cancer. JCO Precis Oncol. 2025 Jun; 9:e2400640.
Score: 0.086
-
Ortendahl JD, Cuyun Carter G, Thakkar SG, Bognar K, Hall DW, Abdou Y. Value of next generation sequencing (NGS) testing in advanced cancer patients. J Med Econ. 2024 Jan-Dec; 27(1):519-530.
Score: 0.079
-
Ortendahl JD, Carter GC, Zantema EM, Hoag JR, Starodynov A, White KL, Basu GD, Tharayanil A, De La O JP, Hall DW, Baehner FL. Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumors. J Med Econ. 2026 Dec; 29(1):1046-1058.
Score: 0.023
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|